S&P 500   3,916.64
DOW   31,861.98
QQQ   305.36
Deal for UBS to buy Credit Suisse sends shares tumbling
Modern Day Options Trading For Beginners! (Ad)pixel
Gunmen kill 9 Chinese at mine in Central African Republic
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Modern Day Options Trading For Beginners! (Ad)pixel
Niinistö: Sweden security OK if Finland joins NATO first
Scottish independence at crossroads in testy SNP leader race
Modern Day Options Trading For Beginners! (Ad)pixel
Swiss bank USB is acquiring smaller rival Credit Suisse for over $3 billion
UK aims to send migrants to Rwanda in months if courts agree
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.36
Deal for UBS to buy Credit Suisse sends shares tumbling
Modern Day Options Trading For Beginners! (Ad)pixel
Gunmen kill 9 Chinese at mine in Central African Republic
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Modern Day Options Trading For Beginners! (Ad)pixel
Niinistö: Sweden security OK if Finland joins NATO first
Scottish independence at crossroads in testy SNP leader race
Modern Day Options Trading For Beginners! (Ad)pixel
Swiss bank USB is acquiring smaller rival Credit Suisse for over $3 billion
UK aims to send migrants to Rwanda in months if courts agree
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.36
Deal for UBS to buy Credit Suisse sends shares tumbling
Modern Day Options Trading For Beginners! (Ad)pixel
Gunmen kill 9 Chinese at mine in Central African Republic
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Modern Day Options Trading For Beginners! (Ad)pixel
Niinistö: Sweden security OK if Finland joins NATO first
Scottish independence at crossroads in testy SNP leader race
Modern Day Options Trading For Beginners! (Ad)pixel
Swiss bank USB is acquiring smaller rival Credit Suisse for over $3 billion
UK aims to send migrants to Rwanda in months if courts agree
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.36
Deal for UBS to buy Credit Suisse sends shares tumbling
Modern Day Options Trading For Beginners! (Ad)pixel
Gunmen kill 9 Chinese at mine in Central African Republic
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Modern Day Options Trading For Beginners! (Ad)pixel
Niinistö: Sweden security OK if Finland joins NATO first
Scottish independence at crossroads in testy SNP leader race
Modern Day Options Trading For Beginners! (Ad)pixel
Swiss bank USB is acquiring smaller rival Credit Suisse for over $3 billion
UK aims to send migrants to Rwanda in months if courts agree
NYSE:ALC

Alcon - ALC Stock Forecast, Price & News

$65.40
-1.38 (-2.07%)
(As of 03/17/2023 08:53 PM ET)
Add
Compare
Today's Range
$65.30
$66.06
50-Day Range
$64.46
$77.23
52-Week Range
$55.21
$81.97
Volume
1.06 million shs
Average Volume
885,908 shs
Market Capitalization
$32.05 billion
P/E Ratio
97.61
Dividend Yield
N/A
Price Target
$79.80

Alcon MarketRank™ Forecast

Analyst Rating
Hold
2.44 Rating Score
Upside/​Downside
22.0% Upside
$79.80 Price Target
Short Interest
Healthy
1.16% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
15.83%
From $2.59 to $3.00 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.36 out of 5 stars

Medical Sector

188th out of 983 stocks

Ophthalmic Goods Industry

4th out of 7 stocks


ALC stock logo

About Alcon (NYSE:ALC) Stock

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland.

Receive ALC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alcon and its competitors with MarketBeat's FREE daily newsletter.

ALC Stock News Headlines

[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Alcon's Debt Overview
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Alcon Inc.: Raising target to $85
Alcon (ALC) Gains From Innovation, Faces FX Challenges
Alcon Prices US$1.3 Billion Senior Notes Offering
See More Headlines
Receive ALC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alcon and its competitors with MarketBeat's FREE daily newsletter.

ALC Company Calendar

Last Earnings
2/27/2023
Today
3/20/2023
Next Earnings (Estimated)
5/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
04544X30
Employees
25,000
Year Founded
1945

Price Target and Rating

Average Stock Price Forecast
$79.80
High Stock Price Forecast
$92.00
Low Stock Price Forecast
$68.80
Forecasted Upside/Downside
+22.0%
Consensus Rating
Hold
Rating Score (0-4)
2.44
Research Coverage
9 Analysts

Profitability

Net Income
$335 million
Pretax Margin
5.31%

Debt

Sales & Book Value

Annual Sales
$8.72 billion
Cash Flow
$4.43 per share
Book Value
$40.15 per share

Miscellaneous

Free Float
482,638,000
Market Cap
$32.05 billion
Optionable
Not Optionable
Beta
0.89

Social Links


Key Executives

  • David J. Endicott
    Chief Executive Officer & Director
  • Timothy C. Stonesifer
    Chief Financial Officer & Senior Vice President
  • Edward McGough
    Head-Global Manufacturing & Technical Operations
  • Franck Leveiller
    SVP, Head-Global Research & Development
  • Sue-Jean Lin
    SVP, Chief Information & Transformation Officer













ALC Stock - Frequently Asked Questions

Should I buy or sell Alcon stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last twelve months. There are currently 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ALC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALC, but not buy additional shares or sell existing shares.
View ALC analyst ratings
or view top-rated stocks.

What is Alcon's stock price forecast for 2023?

9 equities research analysts have issued twelve-month price objectives for Alcon's stock. Their ALC share price forecasts range from $68.80 to $92.00. On average, they anticipate the company's stock price to reach $79.80 in the next year. This suggests a possible upside of 22.0% from the stock's current price.
View analysts price targets for ALC
or view top-rated stocks among Wall Street analysts.

How have ALC shares performed in 2023?

Alcon's stock was trading at $68.55 on January 1st, 2023. Since then, ALC stock has decreased by 4.6% and is now trading at $65.40.
View the best growth stocks for 2023 here
.

Are investors shorting Alcon?

Alcon saw a drop in short interest during the month of February. As of February 28th, there was short interest totaling 5,720,000 shares, a drop of 5.9% from the February 13th total of 6,080,000 shares. Based on an average daily trading volume, of 846,700 shares, the days-to-cover ratio is currently 6.8 days. Currently, 1.2% of the shares of the stock are short sold.
View Alcon's Short Interest
.

When is Alcon's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023.
View our ALC earnings forecast
.

How were Alcon's earnings last quarter?

Alcon Inc. (NYSE:ALC) released its earnings results on Monday, February, 27th. The healthcare company reported $0.42 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.42. The healthcare company earned $2.17 billion during the quarter, compared to analysts' expectations of $2.14 billion. Alcon had a net margin of 3.84% and a trailing twelve-month return on equity of 5.66%.

How often does Alcon pay dividends? What is the dividend yield for Alcon?

Alcon announced a dividend on Saturday, April 23rd. Investors of record on Monday, May 2nd will be paid a dividend of $0.13 per share on Tuesday, May 3rd. This represents a yield of 0.18%. The ex-dividend date is Friday, April 29th.
Read our dividend analysis for ALC
.

What guidance has Alcon issued on next quarter's earnings?

Alcon updated its FY23 earnings guidance on Tuesday, February, 28th. The company provided EPS guidance of $2.55-2.65 for the period, compared to the consensus earnings per share estimate of $2.54. The company issued revenue guidance of $9.2-9.4 billion, compared to the consensus revenue estimate of $9.26 billion.

What is Greg D. Wight's approval rating as Alcon's CEO?

6 employees have rated Alcon Chief Executive Officer Greg D. Wight on Glassdoor.com. Greg D. Wight has an approval rating of 100% among the company's employees. This puts Greg D. Wight in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Alcon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alcon investors own include AT&T (T), Novartis (NVS), Verizon Communications (VZ), International Business Machines (IBM), Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Exxon Mobil (XOM) and AbbVie (ABBV).

What is Alcon's stock symbol?

Alcon trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALC."

Who are Alcon's major shareholders?

Alcon's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Credit Suisse AG (2.68%), Norges Bank (2.39%), Clearbridge Investments LLC (2.09%), Zurcher Kantonalbank Zurich Cantonalbank (1.49%), T. Rowe Price Investment Management Inc. (1.30%) and Brown Brothers Harriman & Co. (1.15%).

How do I buy shares of Alcon?

Shares of ALC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alcon's stock price today?

One share of ALC stock can currently be purchased for approximately $65.40.

How much money does Alcon make?

Alcon (NYSE:ALC) has a market capitalization of $32.05 billion and generates $8.72 billion in revenue each year. The healthcare company earns $335 million in net income (profit) each year or $0.67 on an earnings per share basis.

How many employees does Alcon have?

The company employs 25,000 workers across the globe.

Does Alcon have any subsidiaries?
The following companies are subsidiares of Alcon: Alcon (China) Ophthalmic Product Co. Ltd., Alcon Finance Corporation, Alcon Japan Ltd., Alcon Laboratories Inc., Alcon Pharmaceuticals Ltd., Alcon Research LLC, and Alcon Vision LLC.
Read More
How can I contact Alcon?

Alcon's mailing address is Rue Louis-d`Affry 6, Fribourg V8, 1701. The official website for the company is www.alcon.com. The healthcare company can be reached via phone at 418172930450, via email at investor.relations@alcon.com, or via fax at 41-58-911-3222.

This page (NYSE:ALC) was last updated on 3/20/2023 by MarketBeat.com Staff